Kalaris Therapeutics, Inc.
KLRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001754068
No open-market purchases or sales by Kalaris Therapeutics, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Kalaris Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- −11 vs. Q2 2024
- Shares held
- 44.9M
- −1.32M (−2.9%) vs. Q2 2024
- Total value
- $36.3M
- +$2.87M (+8.6%) vs. Q2 2024
- New holders
- 3
- 5 more added
- Sold out
- 14
- 30 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KLRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $73.4M |
| Q1 2026 | 58 | $107.2M |
| Q4 2025 | 51 | $151.9M |
| Q3 2025 | 32 | $76.4M |
| Q2 2025 | 30 | $35.7M |
| Q1 2025 | 32 | $111.4M |
| Q4 2024 | 53 | $20.7M |
| Q3 2024 | 60 | $36.3M |
| Q2 2024 | 72 | $33.9M |
| Q1 2024 | 77 | $36.4M |
| Q4 2023 | 82 | $28.5M |
| Q3 2023 | 90 | $115.5M |
| Q2 2023 | 94 | $183.6M |
| Q1 2023 | 89 | $156.0M |
| Q4 2022 | 86 | $193.1M |
| Q3 2022 | 87 | $293.7M |
| Q2 2022 | 84 | $109.6M |
| Q1 2022 | 84 | $184.1M |
| Q4 2021 | 84 | $329.4M |
| Q3 2021 | 80 | $640.3M |
| Q2 2021 | 84 | $521.8M |
| Q1 2021 | 75 | $624.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Kalaris Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 8 | $6 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 451 | $365 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 695 | $562 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 862 | $697 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 990 | $800 | 0.00% | −6,655−87.1% | Reduced |
| Parallel Advisors, LLC | 1,145 | $926 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1,004 | $1.00K | 0.00% | −1,271−55.9% | Reduced |
| JPMorgan Chase & Co | 2,178 | $1.76K | 0.00% | −4,584−67.8% | Reduced |
| UBS Group AG | 2,222 | $1.80K | 0.00% | −35,059−94.0% | Reduced |
| Tower Research Capital LLC (TRC) | 2,319 | $1.88K | 0.00% | −18,239−88.7% | Reduced |
| IFP Advisors, Inc | 3,000 | $2.43K | 0.00% | 00.0% | Unchanged |
| Strengthening Families & Communities, LLC | 6,200 | $5.01K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 10,478 | $8.47K | 0.00% | −5,636−35.0% | Reduced |
| Catalyst Funds Management Pty Ltd | 13,000 | $10.5K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 13,214 | $10.7K | 0.00% | −2,016−13.2% | Reduced |
| Point72 (DIFC) Ltd | 14,200 | $11.5K | 0.00% | −3,027−17.6% | Reduced |
| JustInvest LLC | 14,331 | $11.6K | 0.00% | −7,879−35.5% | Reduced |
| PFG Investments, LLC | 16,000 | $12.9K | 0.00% | −3,000−15.8% | Reduced |
| Advisor Group Holdings, Inc. | 18,700 | $15.1K | 0.00% | +3,700+24.7% | Added |
| Cubist Systematic Strategies, LLC | 19,997 | $16.2K | 0.00% | −29,819−59.9% | Reduced |
| AQR Capital Management LLC | 20,843 | $16.9K | 0.00% | −64,925−75.7% | Reduced |
| Bank of America Corp | 24,118 | $19.5K | 0.00% | +1,790+8.0% | Added |
| XTX Topco Ltd | 26,523 | $21.4K | 0.00% | −20,710−43.8% | Reduced |
| Susquehanna International Group, LLP | 27,213 | $22.0K | 0.00% | −140,893−83.8% | Reduced |
| Point72 Asia (Singapore) Pte. Ltd. | 30,261 | $24.5K | 0.00% | −46,017−60.3% | Reduced |
| Qube Research & Technologies Ltd | 34,341 | $27.8K | 0.00% | −44,471−56.4% | Reduced |
| Lido Advisors, LLC | 39,322 | $31.8K | 0.00% | −40,094−50.5% | Reduced |
| Amundi | 45,448 | $36.0K | 0.00% | +45,448 | New |
| Morgan Stanley | 47,380 | $38.3K | 0.00% | −22,572−32.3% | Reduced |
| Tudor Investment Corp Et Al | 49,620 | $40.1K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 57,055 | $46.1K | 0.00% | −287,507−83.4% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 60,500 | $48.9K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 69,769 | $56.3K | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 82,336 | $66.6K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 83,351 | $67.4K | 0.00% | −89,680−51.8% | Reduced |
| Citadel Advisors LLC | 84,200 | $68.1K | 0.00% | −23,078−21.5% | Reduced |
| Price T Rowe Associates Inc | 85,900 | $70.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 93,308 | $75.4K | 0.00% | −194,682−67.6% | Reduced |
| Northern Trust Corp | 158,418 | $128.1K | 0.00% | −278,913−63.8% | Reduced |
| Marquette Asset Management, LLC | 178,883 | $144.6K | 0.02% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 201,000 | $163.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 222,439 | $179.8K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 224,343 | $181.0K | 0.00% | −951,611−80.9% | Reduced |
| Two Sigma Investments, LP | 295,161 | $238.6K | 0.00% | −56,814−16.1% | Reduced |
| D. E. Shaw & Co., Inc. | 296,461 | $239.7K | 0.00% | −179,124−37.7% | Reduced |
| FMR LLC | 310,604 | $251.1K | 0.00% | +1,744+0.6% | Added |
| Marshall Wace, LLP | 324,658 | $263.0K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 449,014 | $363.0K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 508,300 | $411.0K | 0.00% | −125,700−19.8% | Reduced |
| Geode Capital Management, LLC | 585,548 | $473.5K | 0.00% | −61,929−9.6% | Reduced |
| BML Capital Management, LLC | 603,086 | $487.6K | 0.29% | 00.0% | Unchanged |
| BlackRock, Inc. | 632,890 | $511.7K | 0.00% | +632,890 | New |
| Renaissance Technologies LLC | 776,857 | $628.1K | 0.00% | −14,343−1.8% | Reduced |
| Acuitas Investments, LLC | 1,069,696 | $864.8K | 0.39% | +84,863+8.6% | Added |
| Redmile Group, LLC | 1,907,969 | $1.54M | 0.09% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,647,010 | $2.14M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 3,284,800 | $2.66M | 0.00% | −10,929−0.3% | Reduced |
| Siren, L.L.C. | 6,597,167 | $5.33M | 0.27% | +6,597,167 | New |
| Octagon Capital Advisors LP | 11,202,000 | $9.06M | 1.45% | +1,402,000+14.3% | Added |
| EcoR1 Capital, LLC | 11,294,585 | $9.13M | 0.31% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −6,597,167−100.0% | Sold out |
| Pennant Investors, LP | 0 | $0 | 0.00% | −215,700−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −194,473−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −137,897−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −51,224−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −31,765−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −26,032−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −18,494−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −15,947−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −14,565−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −9,294−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −2,561−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −467−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −683−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |